HSV-1 vs HSV-2 — What's the Difference and Why It Matters

HSV-1 and HSV-2 are both herpes simplex viruses. They look similar under a microscope, cause similar-looking sores, and respond to the same antivirals. But they behave differently — different transmission patterns, different outbreak frequencies, different long-term outcomes. If you've just been diagnosed and only know "herpes," finding out which one matters more than people think.

Here's the practical breakdown.

The big picture

Where each virus prefers to live

Both viruses establish lifelong latency in nerve cells (ganglia). The difference is which nerve they prefer:

HSV-1 prefers the trigeminal ganglion (which supplies the face). When it reactivates from there, it causes a cold sore on the lip or mouth — its "home turf." When HSV-1 infects genital skin (through oral sex), it can establish latency in the sacral ganglion (which supplies the genitals), but it's less comfortable there. This is why HSV-1 genital infections recur much less often than HSV-2 genital infections.

HSV-2 strongly prefers the sacral ganglion. When it reactivates, it produces genital outbreaks. HSV-2 oral infection is possible but extremely rare and tends to recur very infrequently.

The key insight: HSV-1 and HSV-2 both can infect either site, but each is comfortable in its preferred site and quietly persistent in the other.

Outbreak frequency expectations

This is the practical question most people want answered.

HSV-2 genital (the classic "genital herpes"):

• Year 1 average: 4-8 outbreaks
• Year 5 average: 2-4 outbreaks (declines over time)
• Some people: rare or no outbreaks despite positive test (called "asymptomatic" or "unrecognized" carriers)

HSV-1 genital:

• Year 1 average: 0-2 outbreaks
• Subsequent years: often zero
• Many people have a single first outbreak and never another

HSV-1 oral (cold sores):

• Highly variable. Some people: 1 cold sore per year. Others: monthly.
• UV exposure, stress, and illness are common triggers.

HSV-2 oral: Extremely rare.

These are averages — your individual experience can vary widely.

Transmission patterns

HSV-1 is mostly acquired in childhood through non-sexual contact:

• Kissing relatives
• Sharing utensils
• Asymptomatic shedding from a parent or caregiver

About two-thirds of people have HSV-1 by adulthood, most without ever having had a recognized outbreak.

In adulthood, HSV-1 can be transmitted through oral sex (oral → genital) or kissing.

HSV-2 is almost always sexually transmitted in adulthood:

• Vaginal sex
• Anal sex
• Oral sex (less common)

Modern epidemiology has changed the picture: about half of new genital herpes diagnoses in the US are now HSV-1, driven by oral sex. This is a meaningful shift from 20 years ago when genital herpes was almost exclusively HSV-2.

Testing — which one do you have?

If you've been tested but only know "you have herpes," ask your doctor specifically:

• Was the test type-specific IgG? Standard since the early 2000s.
• What were the index values for HSV-1 and HSV-2 separately?

A type-specific IgG test reports HSV-1 and HSV-2 separately:

• HSV-1 IgG positive → you have HSV-1 (somewhere — could be oral or genital)
• HSV-2 IgG positive → you have HSV-2 (almost certainly genital)
• Both positive → you have both

A swab from an active lesion (PCR or culture) tells you which type is causing that specific lesion — useful when the location is ambiguous (e.g., oral but in someone with no history of cold sores).

For more on test interpretation, see our HSV test results guide.

Cross-protection: does having one protect you from the other?

Sort of. Having HSV-1 provides partial protection against acquiring HSV-2:

• Reduces severity of HSV-2 first outbreak if you get it
• Doesn't prevent HSV-2 acquisition, but lessens it
• Doesn't change long-term HSV-2 outcomes once you have it

Having HSV-2 doesn't meaningfully protect against acquiring HSV-1.

Treatment differences

Both HSV-1 and HSV-2 respond to the same antivirals (valacyclovir, acyclovir, famciclovir). Treatment differs by:

• Site of infection — oral vs genital affects topical treatment relevance
• Outbreak frequency — suppressive therapy more often used for HSV-2 genital
• Recurrence pattern — HSV-1 genital usually doesn't need long-term suppression

Transmission risk to a partner

HSV-2 to HSV-negative partner (without precautions): ~5-10% per year HSV-2 to HSV-negative partner (with daily suppressive antiviral + condoms): ~1-2% per year HSV-1 oral to HSV-negative partner (kissing during outbreak): substantial — single kiss with active cold sore is high risk HSV-1 genital to HSV-negative partner: lower than HSV-2, especially in years 2+

Pregnancy and HSV

HSV-1 and HSV-2 carry different risks in pregnancy:

• First-time HSV acquisition during late pregnancy (either type) — highest risk to baby (~30-50% transmission). Avoid sex partners with HSV in late pregnancy if you're seronegative.
• Longstanding HSV-2 — baby risk during delivery is low (~0.04%) if no active outbreak. Suppressive valacyclovir starting at week 36 reduces outbreak risk at delivery.
• HSV-1 genital recurrence at delivery — about half the risk of HSV-2 genital recurrence at delivery for transmission.

C-section is recommended if active lesions or prodrome present at labor.

Stigma is different — even though the virus is similar

This is where psychology meets epidemiology. HSV-1 is so common that people don't think of cold sores as "herpes" — even though they're caused by the same virus. HSV-2 is socially burdened.

If you're newly diagnosed with HSV-2: you have what about 1 in 8 adults have. If with HSV-1: you have what about 2 in 3 adults have. Neither is unusual; only one carries social weight, and that weight is built on misunderstanding.

Practical takeaways

1. Get the type-specific test result. Knowing HSV-1 vs HSV-2 changes outbreak expectations and transmission risk.
2. HSV-1 genital is generally easier to live with than HSV-2 genital — fewer outbreaks, lower transmission risk over time.
3. Both respond to the same antivirals. Treatment is similar; you have the same toolkit.
4. Suppressive therapy makes more sense for HSV-2 genital with frequent recurrences than HSV-1 genital.
5. Disclosure ethics are the same regardless of type — partner has a right to know before sex.

Bottom line

HSV-1 and HSV-2 are the same family but different viruses with different behaviors. HSV-1 is more common, often acquired in childhood, mostly oral but increasingly genital. HSV-2 is less common, almost always sexually transmitted in adulthood, and more reliably genital with more frequent recurrences.

If you're newly diagnosed, get the type-specific result. The "which one" answer shapes the next few decades of how you manage this.

For more on herpes — outbreak management, treatment options, cure trials, life after diagnosis — see our complete herpes pillar guide.